. Like the biofilms formed by bacterial pathogens, Candida spp. biofilms are resistant to many antimicrobial agents, so treatment can require surgical removal and later replacement of the infected device 5, 7 . Here, we review Candida spp. biofilm development with a focus on Candida albicans, the most frequently isolated Candida pathogen 10 .
Candida albicans biofilm development C. albicans biofilms consist of two main kinds of cells: small oval yeast-form cells (also called blastospores) and long tubular hyphal cells. C. albicans biofilms grown in vitro often have a foundation of yeast cells, from which a hyphal layer emanates 5 (FIG. 1a) . Extracellular matrix material is also clearly evident and is bound to both yeast and hyphal cells. It is typically interspersed throughout the biofilm, although in FIG. 1a it is mainly apparent at the top of the sample. Biofilms from in vivo catheter infection models seem to be more complex, with yeast cells and hyphae being interspersed 11 (FIG. 1b) . Genetic analyses indicate that both yeast cells and hyphae are crucial for biofilm formation, which suggests that each cell type has a unique role in the process 5 .
In vitro experiments allow C. albicans biofilm development to be viewed as a series of sequential steps 5, 12 (FIG . 2) . Biofilm formation begins with adherence of yeast cells to a substrate (the adherence step; FIG. 2) . Soon afterwards, the yeast cells proliferate across the surface and produce elongated projections that grow into filamentous forms, including hyphae and pseudohyphae (the initiation step). Extracellular matrix accumulates as the biofilm matures, and high-level drug resistance is also acquired (the maturation step). Finally, non-adherent yeast cells are released from the biofilm into the surrounding medium (the dispersal step). Although these steps might occur concurrently rather than sequentially during natural biofilm development in vivo, they provide a useful framework with which to guide a mechanistic analysis of C. albicans biofilm development.
Simple inferences from biofilm genetics
Recent progress in expression profiling and genetic manipulation has increased our understanding of the regulatory pathways and mechanisms that govern C. albicans biofilm development and biofilm-based drug resistance. In addition, such analyses have pointed to an intriguing relationship between biofilm formation and mating. On the basis of known mutant phenotypes, it is clear that C. albicans genes can have net positive or negative roles in biofilm development. This distinction is useful when thinking about the relationships between genes, because a gene product with a negative effect can function by inhibiting a gene product with a positive effect, for example. In addition, it is worth bearing in mind that biofilm dispersal involves an unravelling of the steps involved in biofilm formation. Therefore, the negative function of yeast-form cell wall protein 1 (ywp1) in the adherence step that leads to biofilm formation might go hand in hand with a positive function in biofilm dispersal, for example.
The genes that govern C. albicans biofilm development (TABLE 1) fit into several broad functional categories. Many of these genes are required for the production of hyphae (filamentation). Some of the first C. albicans biofilm genetic studies indicated that hyphae are required for stable biofilm formation 13, 14 . In addition, several biofilm genes are involved in the response to the quorum sensing molecule farnesol 15, 16 . Farnesol is an inhibitor of filamentation 15, 16 and, as might be expected, it inhibits biofilm formation in vitro 17 . In fact, several quorum sensing molecules accumulate in mature biofilms (BOX 1) and the addition of such molecules to biofilm cultures in vitro indicates that they can promote biofilm dispersal [18] [19] [20] . Several noteworthy classes of gene products govern the properties of C. albicans biofilms, including known or predicted cell wall proteins. These proteins are of special interest because they might have a direct role in cell-substrate or cell-cell adherence. Indeed, heterologous expression studies indicate that a putative cell wall adhesin, enhanced adherence to polystyrene 1 (Eap1), as well as hyphal wall protein 1 (Hwp1), agglutinin-like sequence 1 (Als1) and Als3 have such roles [21] [22] [23] . Surface proteins are of further interest as accessible therapeutic targets. Finally, it has become increasingly evident that cell heterogeneity is a crucial feature of biofilms 24 . This attribute is obvious from the different cell types that are seen in C. albicans biofilms (FIG. 1) , and the genes that encode fungal cell wall proteins are subject to both genetic and epigenetic mechanisms that further contribute to cell heterogeneity 25, 26 . Many of the C. albicans genes involved in biofilm development encode predicted transcription factors or protein kinases. These regulatory proteins must function indirectly to control biofilm properties, but can be informative indicators of the internal and external signals that influence biofilm development. For example, a transcription factor, biofilm and cell wall regulator 1 (Bcr1), is required for biofilm formation, and its expression is upregulated in hyphae, thus indicating that Bcr1-dependent gene products might be the hyphal components that are required for biofilm formation 27, 28 . Similarly, the zinc-responsive transcription factor Zap1 (also known as Csr1 and Sur1) is a regulator of extracellular matrix accumulation, indicating that alterations in zinc levels might alter matrix formation 29 . The signals that influence the activity of many of the other biofilm regulators listed in TABLE 1 are not well understood, which presents an opportunity for future study.
Several alcohol dehydrogenases and aryl-alcohol dehydrogenases have an impact on biofilm development. The fact that both positive and negative roles have been found for these proteins indicates that substrate specificity is crucial for their biological function 29, 30 . Although it is possible that their substrates and products function primarily through effects on intermediary metabolism, we note that the aryl-alcohol dehydrogenases in particular have been implicated in the synthesis of amino acid-derived alcohols, which might function in quorum sensing 19, 31, 32 .
we have assembled a model that connects the steps involved in C. albicans biofilm development with biofilm genes and regulatory pathways (FIG. 2) . The regulatory relationships shown are based on diverse lines of evidence, which include mutant phenotypes, genetic epistasis tests, microarray analyses, gene overexpression phenotypes and chromatin immunoprecipitation assays. Thus, some pathway relationships are indirect or tentative. The model is intended as a framework for the identification of new areas of inquiry and for interpretation of future studies. 
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Perhaps the best use of a model for gene function in biofilm development is its application to in vivo models of biofilm formation on implanted devices 11, [33] [34] [35] . In vivo models are crucially important because the nature of the device surface, the presence of host-derived conditioning film, the amounts of oxygen and carbon dioxide, and liquid flow all affect biofilm development 12, [36] [37] [38] . Thus, it is impossible to duplicate in vitro all the conditions that are relevant in vivo.
Diversity of biofilm environments and cohabitants
Many studies have focused on the formation of C. albicans biofilms on implanted vascular catheters, because this is a major source of infection 7 . However, biofilms can also be formed on many other devices. A rat denture biofilm model that recapitulates features of denture stomatitis has been described recently 33 . Microscopic and microbiological analyses showed the signature features of biofilm development: adherent cells, the presence of extracellular matrix material, and high-level drug resistance. The biofilms in one other recently described rat model, involving subcutaneously implanted catheters, also had characteristic matrix material and an abundant hyphal population 34 . This model provides both ethical and technical advantages because a single animal can be used to culture numerous biofilms.
Biofilms also form on tissue surfaces, including the oral and vaginal mucosa. In such infection models, C. albicans produces dense three-dimensional biofilms that are embedded in extracellular matrix material 39, 40 . The level of biofilm drug resistance in these models has not been tested directly, although drug resistance is seldom a clinical problem with vaginal candidiasis 40 . Is biofilm formation in these new environments mechanistically distinct from the more commonly studied in vitro and in vivo models? There are certainly some conserved features. For example, biofilm formation in most of the models described here depends on the transcription factor Bcr1 33,34,40 . where tested, strains that were defective for filamentation were also defective for biofilm formation 34, 40 . However, on the basis of results from the systematic manipulation of in vitro biofilm environments 38 , and given the pronounced gene expression responses of C. albicans to distinct host niches 41 , it is likely that distinct genetic requirements and mechanisms will emerge for each system.
For any one type of biofilm, the environment can be altered by the presence of co-infecting microorganisms. The overall frequency of mixed-species biofilm infections has not been reported, but >20% of bloodstream infections involving Candida spp. are polymicrobial 42 . In a recent analysis of 24 cases of endocarditis associated with an implanted device, ~25% of the infections were found to be polymicrobial 43 . In biofilms grown in vitro, the interactions between bacteria and C. albicans are diverse 44 . Symbiotic interactions can result in augmented adherence and antibiotic resistance 45, 46 . However, most of the known interactions are inhibitory. Among the most intriguing examples are those that arise from trans-kingdom responses to quorum sensing molecules. For example, farnesol produced by fungi inhibits the formation of Staphylococcus aureus biofilms and increases the antibiotic susceptibility of the bacterium 47, 48 . Bacteria can fight back, however; for example, the Pseudomonas aeruginosa quorum sensing molecule homoserine lactone mimics farnesol, inhibiting C. albicans filamentation and thus preventing the formation of C. albicans biofilms 49 . Other inhibitory interactions arise from broader environmental manipulations; for example, vaginal bacteria inhibit C. albicans growth and virulence by producing H 2 O 2 or lactic acid 44, 50 . The importance of further study in this area is demonstrated by the fact that the presence of combined infection by both bacteria and C. albicans can result in increased mortality 51, 52 .
Adherence and attachment responses
The gene products that have been assigned to the adherence step (FIG. 2) have been shown by either null-mutant analysis or heterologous-expression studies to affect the binding of C. albicans to a plastic or protein-coated substrate. One of the most clearly defined biofilm adhesins that mediates surface binding is Eap1 21, 53 . Eap1 has sequence features that are commonly found in fungal cell surface proteins 54, 55 , including a signal sequence and an amino acid composition that is rich in the prospective glycosylation acceptors serine and threonine. The protein also contains internal repeats of a peptide motif, Trp-Pro-Cys-Leu, that is found in numerous fungal cell surface proteins. Finally, it has a short carboxy-terminal sequence that directs the attachment of a glycosylphosphatidylinositol (GPI) anchor. GPI-linked proteins are found in many eukaryotes, in which the GPI moiety tethers proteins to the plasma membrane. However, C. albicans and many other fungi can cleave this anchor and then transfer the cleavage product and attached protein to form a covalent linkage with β-glucan in the cell wall 54, 55 . Several approaches indicate that Eap1 is indeed a GPI-linked cell wall protein 53 . Three observations indicate that Eap1 functions directly in biofilm adherence: expression of the protein in a non-adherent Saccharomyces cerevisiae strain confers adherence to polystyrene; a C. albicans eap1 -/-deletion mutant has reduced adherence to polystyrene; and a C. albicans eap1 -/-deletion mutant is defective in biofilm formation, as assayed both in vitro and in an in vivo catheter model 53, 56 . The closely related cell wall proteins Als1 and Als3 might also function in biofilm surface attachment 57 . Expression of Als1 or Als3 in S. cerevisiae promotes binding to several different protein-coated substrates 58 , which may resemble the conditioned surface of an implanted device. In addition, a C. albicans mutant lacking both ALS1 and ALS3 is defective in biofilm formation in vitro and in vivo 22 . In particular, catheter surfaces inoculated with the double mutant are virtually devoid of cells after incubation in vivo 22 , as would be expected if the mutant has a severe substrate adherence defect.
The idea that Eap1 and Als1 might function in the initial adherence step is consistent with the fact that expression of both genes is detectable in cells grown as either yeast or hyphal cell types 56, 59 . This is not the case for Als3, which is expressed primarily or exclusively in hyphae 59 . It is possible that the initial adherence step that leads to biofilm formation in vivo can be carried out by 60 . In addition, the expression of fusion proteins consisting of GFP fused to the drug efflux proteins Cdr1 or Mdr1 was upregulated following a few minutes of adherence to a glass slide 61 . Thus, C. albicans can sense and respond to surface contact. The regulators that promote attachment responses are unknown, but the transmembrane protein Dfi1 and the mitogen-activated protein kinases Mkc1 and Cek1 (also known as Erk1) are mediators of other surface-dependent responses [62] [63] [64] and are, thus, excellent candidates. Mkc1 is required for normal biofilm formation 64 , and it would be interesting if this requirement were to reflect an effect on adherence-induced gene expression.
Adherence is also highly regulated through a new mating factor response pathway
. Interestingly, this pathway operates in cells that do not mate but rather assist in mating through biofilm formation [65] [66] [67] [68] . The responsive cells are of mating type a/a and thus have the potential to mate with α/α cells. However, they are unable to do so, because they have not made the epigenetic transition from the white, mating-incompetent state to the opaque, mating-competent state 69 . They nonetheless respond to α-factor through a newly evolved hybrid signal transduction pathway 66 to create a biofilm. Four white-cell genes that are induced by α-factor are required for full adherence of this biofilm: the genes that encode the cell surface proteins Eap1 and the predicted GPI-anchored protein 10 (Pga10), the predicted secreted protein Pbr1 and the putative aryl-alcohol dehydrogenase cell surface hydrophobicity 1 (Csh1) 68 . Csh1 has been detected on the C. albicans cell surface 70 , so the nature of its role in adherence is uncertain. Most C. albi cans isolates are a/α cells and do not secrete or respond to mating factor; a/α strains have been used for most of the biofilm studies described in this Review. However, the fact that Eap1, Pga10 and Csh1 all have roles in biofilm formation in a/α cells indicates that both kinds of C. albicans biofilm might use similar gene products 68 .
Biofilm initiation and filamentation
The gene products that have been assigned to the initiation step (FIG. 2) have a range of functions. This diversity results, in part, from our broad definition: these are genes in which mutations cause the production of only a small, rudimentary biofilm in vitro. Overexpression of some of the gene products in this group (Rbt5, Als9 and extent of cell elongation 1 (Ece1)) improves biofilm formation in a bcr1 -/-mutant, which is defective in biofilm initiation (see below). we note that a mutant with a partial adherence defect might be categorized as an initiation mutant; thus, our assignment of gene products to this step is tentative.
The production of hyphae is a hallmark of initiation, and many initiation-defective mutants grow solely as yeast cells under biofilm conditions (TABLE 1) . Bcr1 expression is upregulated in hyphae, although this protein is required for biofilm initiation but not for the production of morphologically normal hyphae 27, 28 . Rather, it is required for normal production of several cell surface proteins, some of which (such as Als3 and Hwp1) are induced in hyphae. The failure to express these surface proteins is the cause of the biofilm defect in the bcr1 -/-mutant, because increased expression of ALS3 or HWP1 in this mutant restores the ability to form biofilms, both in vitro and in vivo 23, 28 (FIG. 3) . Moreover, expression of BCR1 or its target genes can even permit biofilm formation by mutants that are defective in hyphal morphogenesis: specifically, increased expression of BCR1 in a hyphal-defective tec1 -/-mutant permits in vitro formation of a biofilm, albeit a fragile one 28 . In addition, the expression of a surface-directed Als3 fusion protein permits biofilm formation in vitro in a hyphal-defective enhanced filamentous growth 1 (EFG1) deletion mutant 71 . Therefore, the main way that hyphae promote biofilm formation is through expression of their surface protein complement.
Interestingly, the Bcr1 orthologue in the biofilmforming species Candida parapsilosis is also required for biofilm formation in this species 72 . Because C. parap silosis does not form hyphae, the regulatory pathway upstream of Bcr1 may be divergent. nonetheless, this finding points to the possibility that Bcr1 orthologues in other species might also govern biofilm formation.
what do these hyphal surface proteins do? Hyphae are extremely 'sticky' , and both Als3 and Hwp1 are adhesins in some contexts 54 , so it seems reasonable to assume that they might promote cell-cell or cell-substrate binding. In fact, Als3 (along with the closely related Als1) and Hwp1 seem to function as complementary cellcell adhesins, analogous to the mating agglutinins of S. cerevisiae that promote binding between a-cells and
Box 1 | Quorum sensing and Candida albicans biofilms
Quorum sensing phenomena are those in which microbial behaviours or responses are governed by cell density. Such community behaviours are usually determined by secreted signalling molecules, the accumulation of which is a measure of cell density 100 . Quorum sensing has a pivotal role in biofilms of all kinds 101, 102 . The best studied quorum-sensing molecule in Candida albicans is E,E-farnesol, an inhibitor of hyphal formation. Exogenous farnesol inhibits biofilm formation if provided early during adherence 17, 18 . The limited biofilms that form in the presence of farnesol comprise mainly yeast and pseudohyphal cells, rather than hyphae. Farnesol also accumulates in supernatants of mature biofilms 20 , where stimulation of yeast cell production might promote biofilm dispersal. Tyrosol, an alcohol derived from tyrosine, has the opposite activity to farnesol: it stimulates hyphal formation. The addition of exogenous tyrosol does not have a measurable effect on overall biofilm development but can partially overcome the inhibition of biofilm formation by exogenous farnesol 18 . Tyrosol also accumulates in mature biofilm supernatants 18, 20 , and the overall inhibition of hyphal formation by such supernatants 17, 18, 20 seems to reflect the dominant activity of farnesol 18 . Several other small molecules are detectable in biofilm supernatants, including phenylethyl alcohol, dodecanol and nerolidol 20 . Each of these compounds can inhibit hyphal formation, and thus all might aid in biofilm dispersal by promoting yeast cell formation. It will be of interest to block the synthesis of, or response to, individual molecules in order to assess their biological functions, and to test their roles in biofilm development in vivo.
α-cells. Two main observations support this idea. First, both a hwp1 -/-mutant and an als1
-/-als3 -/-double mutant are defective in biofilm formation, but a mixture of the two mutant strains produces a robust biofilm in vitro and in vivo 22 . This finding indicates that Hwp1, Als1 and Als3 have distinct and complementary roles in biofilm formation. Second, expression of HWP1 in S. cerevisiae promotes the adherence of this yeast to hyphae of wild-type C. albicans 22 , but adherence is diminished when tested with hyphae of a C. albicans als1 -/-als3 -/-double mutant. These findings point towards a function of Hwp1, Als1 and Als3 as mediators of cell-cell adherence.
At this juncture, it is possible to propose a minimal pathway of biofilm formation. First, yeast cells express Eap1 and Als1, which mediate cell-substrate binding. Second, surface-bound cells propagate and express Als3 and Hwp1, which mediate cell-cell binding. Hyphae formation might provide a simple pathway that leads to Als3 and Hwp1 accumulation. Als3 would also augment cell-substrate binding, as discussed above. In addition, it has been shown that Eap1 mediates cell-cell binding and cell-substrate binding, so this protein would participate in both processes. Many of the proteins required for biofilm initiation are also required for hyphae formation; in the minimal model, their functions are explained as ultimately being required for ALS3 and HWP1 expression.
However, the roles of some biofilm initiation proteins are less readily explained by the minimal model: the additional cell surface proteins, including Sun41, Csa1, Pga10, Rbt5, Hwp2 and Rbt1 (TABLE 1) . Analysis has been challenging for several of these proteins, because they belong to families with overlapping or compensatory functions (Csa1, Pga10 and Rbt5; Hwp2, Rbt1 and Hwp1; and Sun41 and Sun42) 67, [73] [74] [75] [76] . To study the genes encoding these proteins, strains with mutations in multiple genes are required, but the construction of such mutants is not trivial. In any case, current observations indicate that some of these proteins might function as adhesins. In particular, the additive effects of hwp2 or rbt1 mutation with a hwp1 mutation, along with the known role of Hwp1 as an adhesin, indicate that Hwp2 and Rbt1 are adhesins 67 . For example, they might contribute to a threshold level of cell-cell binding that is required for biofilm stability. In C. parapsilosis, the Bcr1 homologue promotes the expression of RBT1, so perhaps C. parapsilosis Rbt1, which has an important role in biofilm formation 72, 77 , has assumed a predominant adhesin function in this species. A second suggestion is that some of these cell surface proteins have general roles in cell wall structure, and that perturbation of the cell wall architecture impairs adherence through effects on either post-translational modification or the expression of adhesins. It should be noted that loss of Sun41 or Pga10 confers hypersensitivity to cell wall inhibitors, an expected consequence of a general cell wall defect [73] [74] [75] [76] . It is also noteworthy that the amounts of ALS1 RnA are reduced in the biofilm-and cell wall-defective protein kinase mutants gin4 -/-, ire1 -/-and cbk1 -/-, thus indicating that adhesin gene expression might be regulated through cell wall regulatory pathways 78 . The mechanistic contribution of so many cell surface proteins to biofilm formation is a key aspect to be addressed, particularly because such proteins are inviting therapeutic targets.
Biofilm maturation and the extracellular matrix
Biofilm maturation includes continued growth of the biofilm and the accumulation of extracellular matrix material. Genes assigned to this category (FIG. 2) include those that affect matrix production or overall biofilm biomass.
The composition of the matrix that is produced in vitro includes carbohydrate, protein, hexosamine, phosphorus and uronic acid 79 . One main extracellular carbohydrate constituent is β-1,3 glucan, increased production of which is associated with biofilm cells rather than planktonic cells 80 . A proteomic analysis showed the presence of specific proteins associated with the biofilm cell surface; these proteins may include matrix components 30, 81 . Finally, a recent study reported the detection of extracellular DnA 82 , as has been found in bacterial biofilms 83 . Indeed, the addition of Dnase to a mature biofilm partially disrupts the biofilm 79, 82 , and the addition of extracellular DnA at the beginning of biofilm development results in mature biofilms with increased biofilm biomass. Thus, extracellular DnA in the matrix contributes to the structure and stability of a mature biofilm.
The transcription factor Zap1, a regulator of zinc acquisition 84, 85 , is a net negative regulator of biofilm matrix production (FIG. 2) . A zap1 -/-mutant forms a biofilm with elevated levels of matrix β-1,3 glucan in vitro and in vivo 29 . Zap1 activates the expression of CSH1 and IFD6, which have inferred negative roles in matrix production, and represses the expression of the glucoamylase 1 gene (GCA1), GCA2 and the alcohol dehydrogenase 5 gene (ADH5), which have inferred positive roles 29 . Gca1 and Gca2 might function through the hydrolytic release of soluble β-1,3 glucan fragments
Box 2 | Candida albicans mating
One of the most exciting discoveries in Candida albicans research in recent years is the finding that this organism, which was long considered to be asexual, can mate. A mating-type locus called MTL determines sexual identity through regulatory relationships with some similarity to those of . However, mating involves more than just MTL-specified sexual identity; cells must switch from the mating-incompetent white cell type to the mating-competent opaque cell type [105] [106] [107] [108] [109] . The epigenetic white-opaque switch responds to numerous genetic and environmental signals, but it does not seem to be regulated by mating factors 110, 111 . Mating of two C. albicans diploid cells yields a tetraploid that breaks down through chromosome loss to yield recombinant diploid progeny [112] [113] [114] [115] . Normal functioning of the chromosome loss pathway depends on Spo11
116
, orthologues of which function in meiosis in other organisms, but there is no evidence that C. albicans has a complete meiotic pathway.
Although white cells do not mate, they do respond to mating pheromones. The response can be assayed through changes in gene expression and increases in cell-cell and cell-substrate adherence, which stimulate biofilm formation [65] [66] [67] [68] 104, 117 . Interestingly, only a proportion of the opaque pheromone response pathway is used in white cells; they use a hybrid pathway with new downstream components [66] [67] [68] . Opaque cells may be rare in many niches, and the biological role of this white cell biofilm seems to be to facilitate mating among disperse opaque cells 65, 110, 115 . Nature Reviews | Microbiology 
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Ergosterol
The main sterol in the fungal cell membrane. Ergosterol is responsible, and essential, for structural and regulatory membrane features such as fluidity and permeability (equivalent to cholesterol in mammalian cells).
Azole
A class of antifungal drug that inhibits a late step in the biosynthesis of ergosterol; this includes the triazoles (for example, fluconazole, voriconazole and posaconazole) and the imidazoles.
from longer glucan chains. The precise functions of the alcohol dehydrogenase-related proteins Csh1, Ifd6 and Adh5 are unknown, but several similar S. cerevisiae alcohol dehydrogenases function in the synthesis of acyl and aryl alcohols 31, 32, 86, 87 . These alcohols have roles in quorum sensing and cell signalling
, as indicated by effects on hyphal growth, for example [15] [16] [17] [18] 20, 88 . Thus, a possible mechanistic role for these dehydrogenases is to promote the biogenesis of biofilm-associated acyl and aryl alcohols, which, in turn, would control matrix synthesis. Csh1 and Ifd6 might function preferentially to yield a matrix-inhibitory signal, whereas Adh5 might function preferentially to yield a matrix-stimulatory signal 29 . The known role of Zap1 in zinc-responsive gene expression indicates that ambient zinc levels could be a crucial determinant of biofilm matrix formation.
Zap1 could have a broader role in biofilm maturation than simply the control of matrix accumulation. The zap1 -/-mutant has reduced expression of several genes that are normally upregulated in mature biofilms, including those encoding ergosterol biosynthesis enzymes and putative hexose transporters 29 . Thus, Zap1 seems to govern several aspects of biofilm maturation. It will be interesting to see whether any of these mutant phenotypes reflect the postulated alteration of the levels of quorum sensing molecules.
A unique feature of mature biofilms, in addition to matrix accumulation, is the acquisition of highlevel resistance to antifungals 5 , notably the azoles and polyenes that target membrane sterols. The nature of biofilm drug resistance may reflect four distinct mechanisms. First, compared with non-biofilm cells, mature biofilm cells have reduced amounts of membrane sterols 89 and elevated expression of several ergosterol biosynthesis genes 60, 90, 91 , which perhaps reflects hypoxia in these cells 38, 77 . The ability of mature biofilm cells to survive with low sterol levels, combined with elevated levels of biosynthetic enzymes, could contribute to azole and polyene resistance. Indeed, a recent study showed that a polyene-resistant biofilm cell subpopulation displayed substantially increased expression of ergosterol biosynthesis genes 92 . Second, the azole efflux genes CDR1, CDR2 and MDR1 are induced early in biofilm formation and might contribute to overall azole resistance. However, their phenotypic contribution is detectable only in early biofilm cells 89 . Third, as with several bac terial biofilms 93 , C. albicans biofilms contain a subpopulation of persisters that are tolerant to a range of otherwise cidal treatments 94 . The importance of this phenomenon is highlighted by the presence of persisters in human oral C. albicans populations 95 . Persisters do not have the long-term stability of mutants, but are phenotypic variants that may arise from an epigenetic change or, perhaps, transient aneuploidy 96 . Finally, the β-1,3 glucan found in the biofilm matrix binds to and sequesters azole drugs 80 . The physiological importance of this has been demonstrated by the analysis of a C. albicans strain with reduced β-1,3 glucan biosyn thesis capacity (genotype FKS1/fks1 -(also known as GSC1/gsc1 -)) 97 . Biofilms formed by this strain have reduced matrix β-1,3 glucan and reduced azole resistance levels in both in vitro and in vivo models. The dramatic sensitivity of the mutant biofilm cells to azole treatment, particularly in the in vivo biofilm model, indicates that this sequestration mechanism is a major contributor to azole resistance in C. albicans biofilms 97 . 
Cell dispersal
Persister
A metabolically quiescent cell that neither grows nor dies when exposed to cidal concentrations of antimicrobial compounds.
new transcriptional regulators of dispersal (Ume6, Pes1 (also known as nop7) and nrg1) were identified. Overexpression of UME6 reduced the release of cells from a biofilm, and overexpression of either PES1 or NRG1 increased release 98, 99 . Thus, changes in the expression or activity of Ume6, Pes1 or nrg1 during biofilm maturation -perhaps in response to the accumulation of quorum sensing molecules -might control cell dispersal. Finally, dispersed cells have phenotypes that are distinct from those of planktonic cells: dispersed cells display elevated adherence and filamentation capacity, and increased pathogenicity in a disseminated infection model, when compared with planktonic cells. Thus, the dispersal step releases cells that are uniquely equipped to seed new biofilms and sites of infection 98, 99 .
Concluding remarks
C. albicans biofilm formation on implanted devices is a major source of disseminated C. albicans infection. The past decade has seen key advances in the identification of the C. albicans genes that govern biofilm development. In many cases, we have moved forwards from gene discovery to defining pathway relationships and, in some cases, we now have a mechanistic understanding. In addition, numerous quorum sensing molecules with potential roles in biofilm maturation have been defined. Moreover, there are now several animal models for the analysis of biofilm development in vivo that have validated the importance of key biofilm genes discovered in vitro. However, a summary of the progress that has been made to date also shows major gaps in our understanding. How can so many cell wall proteins participate in biofilm formation; are they all adhesins? which quorum sensing molecules are actually active in vivo, and can we harness their activities for the development of therapeutics? Can we use our understanding of biofilm drug resistance to develop better therapeutics and more focused assays of biological activity? what are the dynamics of the formation of -and key molecular players in -mixed-species biofilms? And, perhaps most difficult to answer and most interesting to ponder, what selective pressures caused the evolution of the ability to form biofilms -was it for mating, or for mucosal surface adherence and persistence in the host? There has never been a more interesting time to study C. albicans biofilms.
